Venture Newfoundland and Labrador invests $300k in Sequence Bio
Venture Newfoundland and Labrador, a venture capital fund launched last November, recently completed its debut deal, investing $300,000 in Sequence Bio, a health information and technology data and analytics startup. Based in St. John's, Sequence Bio was founded in 2013 by CEO Tyler Wish and COO Chris Gardner. The company said the funding's proceeds will be used to accelerate its vision for improving patient care by enabling data-driven innovation in the field of precision medicine. Venture Newfoundland and Labrador is managed by Pelorus Venture Capital.
30 July 2015•3 mins read
